Nadunolimab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Nadunolimab, covering 2026-03-09 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer. [Phase 1, Phase 2]